Estradiol Nasal Spray for Patulous Eustachian Tube (PET)
Estradiol 0.5 mg/0.1 mL Nasal Spray in MucoLox™
Quantity: 10 mL
Price: $85 + free UPS Ground Shipping. Login to the Practitioner Portal for all ENT compound pricing.
Sig:Tilt head to side and aim 2 sprays in nostril toward affected Eustachian tube(s) twice daily. Lie down for 10 minutes afterward.
The FDA does not review any compounded medication for safety or efficacy.
What is Estradiol Nasal Spray?
Estradiol 0.5 mg/0.1 mL nasal spray is a compounded, prescription-only medication prepared by a pharmacy for patient-specific use. It contains estradiol, a form of estrogen, formulated into a nasal spray for intranasal administration.
Each 0.1 mL spray delivers 0.5 mg of estradiol, allowing for precise, localized dosing as directed by the prescriber.
In ENT practice, compounded estradiol nasal spray is sometimes considered for patients with patulous Eustachian tube (PET). The proposed treatment approach involves increasing mucosal tissue fullness around the Eustachian tube opening, potentially reducing symptoms such as autophony. However, clinical evidence supporting the effectiveness of intranasal estradiol for PET is limited, and treatment should be individualized by the prescribing provider.
Download our Estradiol Nasal Spray for Patulous Eustachian Tube (PET) Flyer
Clinical Scenarios Where ENTs Explore Estradiol Nasal Spray
ENT specialists may consider compounded estradiol nasal spray in select patients with patulous Eustachian tube (PET), particularly when symptoms are persistent and conservative measures have not provided adequate relief.
Common clinical scenarios include:
- Persistent Symptomatic PET – Patients experiencing ongoing autophony, aural fullness, or audible breathing despite first-line strategies (hydration, positional changes, saline) may be considered for localized therapies such as estradiol nasal spray.
- Weight Loss–Associated PET – PET can occur following significant or rapid weight loss, potentially related to reduced tissue support surrounding the Eustachian tube. In selected patients, ENT specialists may consider compounded estradiol nasal spray as an investigational treatment approach, although evidence of clinical effectiveness remains limited.
- Intermittent or Positional PET – Patients whose symptoms vary with posture or physical activity may require individualized management. ENT specialists may evaluate whether additional treatment options are appropriate when conservative measures are insufficient.
- Patients Seeking Non-Procedural Options – Before moving to procedural interventions (e.g., injections, implants, or surgical approaches), ENTs may trial non-invasive, locally acting therapies such as compounded nasal sprays.
- Adjunct to Other PET Management Strategies – Estradiol nasal spray may be used alongside other supportive approaches as part of a multimodal management plan, depending on provider preference and patient response.
Use of compounded estradiol nasal spray should always be based on clinical judgment and prescribed for an individual patient after appropriate evaluation.
Mechanism of Action
Compounded estradiol nasal spray has been explored as a localized treatment approach for patulous Eustachian tube (PET).
The proposed rationale involves estrogen’s potential effects on mucosal tissue surrounding the nasopharyngeal opening of the Eustachian tube.
The treatment approach is intended to:
Promote localized mucosal tissue fullness near the Eustachian tube opening.
Potentially influence tissue characteristics associated with Eustachian tube closure.
Address symptoms associated with abnormal Eustachian tube patency.
However, these effects have not been conclusively demonstrated in clinical studies of compounded estradiol nasal spray for PET. Evidence supporting its effectiveness remains limited, and treatment decisions should be individualized by the prescribing ENT specialist.
Advantages of Compounded Estradiol Nasal Spray
- Single, well-characterized active ingredient: Contains estradiol rather than a mixture of conjugated estrogens.
- Non-animal-derived estradiol: Offers an alternative to formulations containing conjugated equine estrogens.
- Customizable formulation: Compounded according to the prescriber’s patient-specific requirements, where appropriate.
- Mucoadhesive vehicle (MucoLox™): Formulated with a vehicle designed to promote contact with the nasal mucosa.
- Intranasal administration: Delivers medication to the nasal cavity near the nasopharyngeal opening of the Eustachian tube.
Clinical Considerations
Dosing frequency may be individualized based on patient response and prescriber assessment.
Counsel patients regarding possible local nasal irritation.
Systemic estradiol absorption may occur. Prescribers should consider hormone-related risks, relevant medical history, and appropriate monitoring.
Additional evaluation may be warranted for patients with a history of estrogen-sensitive conditions or other contraindications to estrogen therapy.
Please document “PET” as the diagnosis on the prescription.
Other Applications: Estradiol Nasal Drops for Hereditary Hemorrhagic Telangiectasia
Massey Drugs also compounds estradiol nasal preparations for prescriber-directed use in selected patients with hereditary hemorrhagic telangiectasia (HHT). For HHT, the medication is dispensed as nasal drops rather than a spray, based on the prescriber’s treatment approach and concerns regarding epistaxis. Please document “HHT” as the diagnosis and specify “nasal drops” on the prescription. The appropriate formulation and treatment plan should be determined by the prescribing provider.
Why ENTs Choose Massey Drugs
ENT-focused compounding expertise for otic, nasal, and oral therapies
Flexible dosage forms including drops, sprays, powders, capsules, and rinses
Fast turnaround: Prescriptions are typically processed within 24–48 hours after patient confirmation and payment.
FREE Ground Shipping on all ENT compounded medications
NABP accredited compounding pharmacy
Direct pharmacist access for formulation and clinical support
Transparent pricing available through the Practitioner Portal
States We Serve
Massey Drugs is an NABP-accredited compounding pharmacy licensed to dispense and ship patient-specific compounded ENT medications, including estradiol nasal spray, to patients in the following 16 states:
Alabama, Tennessee, Mississippi, Louisiana, Georgia, Florida, North Carolina, South Carolina, Kentucky, Illinois, Indiana, Ohio, Pennsylvania, New York, Connecticut, and Texas.
How to Prescribe Estradiol Nasal Spray
Download Rx Blank from the Practitioner Portal and send to Massey Drugs:
FAX: 800.637.2601
Phone: 833.540.3500
OR
e-Scribe: NPI#: 1295756245 | NCPDP#: 0127553
Massey Drugs | Cloverdale Road
Upon receipt of prescription, Massey Drugs contacts the patient to confirm shipping address and credit card payment.
Once the patient’s shipping address and payment are confirmed, prescriptions are typically processed and shipped within 24–48 hours.
Massey Drugs provides competitively priced compounded medications with transparent, prescriber-accessible pricing. All compound pricing can be viewed in our Practitioner Portal so costs can be communicated to patients before prescribing.
Speak with a Pharmacist
Have questions about compounded estradiol nasal spray for patulous Eustachian tube (PET)? Our pharmacists are available to discuss formulation details, prescription requirements, and patient-specific considerations with ENT providers.
Call 833-540-3500 or contact us.
Frequentley Asked Questions
Is estradiol nasal spray FDA-approved for this use?
No. Estradiol nasal spray for PET is not an FDA-approved product or indication. It is a compounded medication prepared by a 503A pharmacy pursuant to a valid prescription. Prescribers may choose this option when a commercially available alternative does not meet the patient’s needs.
How long does it typically take to see a response?
There is no well-established timeframe for symptom improvement with compounded estradiol nasal spray for patulous Eustachian tube (PET). Response may vary depending on the patient and the underlying cause of symptoms. Prescribers should determine an appropriate follow-up schedule to evaluate tolerability and whether treatment is providing meaningful relief.
Is estradiol nasal spray the same as Premarin nasal drops?
No. Estradiol and Premarin are different estrogen preparations. Massey Drugs compounds an estradiol 0.5 mg/0.1 mL nasal spray in MucoLox™ for patient-specific prescriptions. Premarin contains conjugated estrogens and is not interchangeable with estradiol on a milligram-for-milligram basis.
Prescribers should specify the intended medication, concentration, and dosage form when submitting a prescription.